Journal
MEDICAL HYPOTHESES
Volume 143, Issue -, Pages -Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.mehy.2020.110124
Keywords
COVID-19 pandemic; Saliva biomarkers; SARS-CoV-2
Categories
Ask authors/readers for more resources
Utilising biomarkers for COVID-19 diagnosis, prediction of treatment response and overall prognostication have been investigated recently. However, these ventures have only considered the use of blood-based molecular markers. Saliva is another biofluid that warrants being applied in similar fashion with major advantages that centres on its non-invasive and repeatable collection as well as cost-efficiency. To this end, this article presents a hypothesis for the sources of biomarkers useful clinically for COVID-19 disease outcome estimation and identify the likely implications of their detection in saliva.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available